MISSISSAUGA, ONTARIO -- (MARKET WIRE) -- August 29, 2006 -- BioSyent Inc. (“BioSyent”)(TSX VENTURE: RX) today released its six month financial results. Product sales for the six months ending June 30, 2006 were $413,364 up $113,103 (+38%) versus the same period in 2005. Gross profit for the period was $274,981, up $101,677 (+59%) versus the six months ending June 30, 2005. Gross margin from product sales for the current year six month period was 63%, compared to 56% in the six months ending June 30, 2005. The loss from operations for the six months ending June 30, 2006 was $7,099, an improvement of $72,308 (+91%) versus the same six month period in 2005.
